| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |